{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:28:36Z","timestamp":1791386916944,"version":"4.3.3"},"reference-count":74,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T00:00:00Z","timestamp":1628208000000},"content-version":"vor","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005196","name":"Chinese Academy of Agricultural Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.cell.2020.06.035","type":"journal-article","created":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T03:49:50Z","timestamp":1593316190000},"page":"722-733.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":487,"title":["A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS"],"prefix":"10.1016","volume":"182","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8352-1327","authenticated-orcid":false,"given":"Lianpan","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enqi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaling","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changwen","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxun","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George F.","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2020.06.035_bib1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.cell.2020.06.035_bib2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/v11010041","article-title":"Bats and Coronaviruses","volume":"11","author":"Banerjee","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.cell.2020.06.035_bib3","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1038\/emi.2017.50","article-title":"A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein","volume":"6","author":"Chen","year":"2017","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.cell.2020.06.035_bib4","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1086\/430301","article-title":"Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong, China","volume":"40","author":"Chiu","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cell.2020.06.035_bib5","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1107\/S0907444994003112","article-title":"The CCP4 suite: programs for protein crystallography","volume":"50","year":"1994","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.cell.2020.06.035_bib6","doi-asserted-by":"crossref","first-page":"6695","DOI":"10.1128\/jvi.66.11.6695-6705.1992","article-title":"Monoclonal antibody analysis of neutralization and antibody-dependent enhancement of feline infectious peritonitis virus","volume":"66","author":"Corapi","year":"1992","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2020.06.035_bib7","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1016\/j.vaccine.2006.10.031","article-title":"Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model","volume":"25","author":"Du","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.cell.2020.06.035_bib8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrmicro2090","article-title":"The spike protein of SARS-CoV--a target for vaccine and therapeutic development","volume":"7","author":"Du","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.cell.2020.06.035_bib9","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.virol.2009.07.018","article-title":"Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E.\u00a0coli cells elicits potent neutralizing antibody and protective immunity","volume":"393","author":"Du","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.cell.2020.06.035_bib10","doi-asserted-by":"crossref","first-page":"e81587","DOI":"10.1371\/journal.pone.0081587","article-title":"A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines","volume":"8","author":"Du","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cell.2020.06.035_bib11","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.cell.2020.06.035_bib12","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1086\/597122","article-title":"Human coronavirus and acute respiratory illness in older adults with chronic obstructive pulmonary disease","volume":"199","author":"Gorse","year":"2009","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.cell.2020.06.035_bib13","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1126\/science.abb8923","article-title":"Rapid COVID-19 vaccine development","volume":"368","author":"Graham","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cell.2020.06.035_bib14","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bbrc.2004.09.106","article-title":"Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine","volume":"324","author":"He","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cell.2020.06.035_bib15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cell.2020.06.035_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1292\/jvms.60.49","article-title":"Antibody-dependent enhancement of feline infectious peritonitis virus infection in feline alveolar macrophages and human monocyte cell line U937 by serum of cats experimentally or naturally infected with feline coronavirus","volume":"60","author":"Hohdatsu","year":"1998","journal-title":"J.\u00a0Vet. Med. Sci."},{"key":"10.1016\/j.cell.2020.06.035_bib17","doi-asserted-by":"crossref","first-page":"34610","DOI":"10.1074\/jbc.M603275200","article-title":"Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R","volume":"281","author":"Hwang","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cell.2020.06.035_bib18","doi-asserted-by":"crossref","first-page":"10582","DOI":"10.1128\/JVI.00671-11","article-title":"Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent Fc\u03b3R pathway","volume":"85","author":"Jaume","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2020.06.035_bib19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/INF.0b013e3182812787","article-title":"Severity and outcome associated with human coronavirus OC43 infections among children","volume":"32","author":"Jean","year":"2013","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.cell.2020.06.035_bib20","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/1471-2334-12-365","article-title":"Coronavirus infections in hospitalized pediatric patients with acute respiratory tract disease","volume":"12","author":"Jev\u0161nik","year":"2012","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.cell.2020.06.035_bib21","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1586\/erv.12.126","article-title":"Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome","volume":"11","author":"Jiang","year":"2012","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.cell.2020.06.035_bib22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.it.2020.03.007","article-title":"Neutralizing antibodies against SARS-CoV-2 and other human coronaviruses","volume":"41","author":"Jiang","year":"2020","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cell.2020.06.035_bib23","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.vaccine.2006.08.011","article-title":"Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in\u00a0vitro","volume":"25","author":"Kam","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.cell.2020.06.035_bib24","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.3389\/fimmu.2018.01093","article-title":"Chaperna-mediated assembly of ferritin-based Middle East respiratory syndrome-coronavirus nanoparticles","volume":"9","author":"Kim","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cell.2020.06.035_bib25","series-title":"Coronaviridae. Fields Virology","author":"Knipe","year":"2013"},{"key":"10.1016\/j.cell.2020.06.035_bib26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cell.2020.06.035_bib27","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.cell.2020.06.035_bib28","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1126\/science.1116480","article-title":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor","volume":"309","author":"Li","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.cell.2020.06.035_bib29","doi-asserted-by":"crossref","first-page":"10108","DOI":"10.1128\/JVI.79.16.10108-10125.2005","article-title":"Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies","volume":"79","author":"Li","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2020.06.035_bib30","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/cr.2015.113","article-title":"A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein","volume":"25","author":"Li","year":"2015","journal-title":"Cell Res."},{"key":"10.1016\/j.cell.2020.06.035_bib31","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3390\/v11090799","article-title":"A novel bacterium-like particle vaccine displaying the MERS-CoV receptor-binding domain induces specific mucosal and systemic immune responses in mice","volume":"11","author":"Li","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.cell.2020.06.035_bib32","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nature12328","article-title":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26","volume":"500","author":"Lu","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.cell.2020.06.035_bib33","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.tim.2015.06.003","article-title":"Bat-to-human: spike features determining \u2018host jump\u2019 of coronaviruses SARS-CoV, MERS-CoV, and beyond","volume":"23","author":"Lu","year":"2015","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.cell.2020.06.035_bib34","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.1016\/j.vaccine.2014.08.086","article-title":"Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments--the importance of immunofocusing in subunit vaccine design","volume":"32","author":"Ma","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.cell.2020.06.035_bib35","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nm.4131","article-title":"A roadmap for MERS-CoV research and product development: report from a World Health Organization consultation","volume":"22","author":"Modjarrad","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2020.06.035_bib36","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1080\/22221751.2020.1743767","article-title":"Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2","volume":"9","author":"Nie","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.cell.2020.06.035_bib37","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.vaccine.2018.02.065","article-title":"Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen","volume":"36","author":"Nyon","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.cell.2020.06.035_bib38","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of X-ray diffraction data collected in oscillation mode","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.cell.2020.06.035_bib39","doi-asserted-by":"crossref","first-page":"E7348","DOI":"10.1073\/pnas.1707304114","article-title":"Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen","volume":"114","author":"Pallesen","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2020.06.035_bib40","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature12005","article-title":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC","volume":"495","author":"Raj","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.cell.2020.06.035_bib41","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1107\/S0907444901012471","article-title":"Pushing the boundaries of molecular replacement with maximum likelihood","volume":"57","author":"Read","year":"2001","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.cell.2020.06.035_bib42","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.cell.2020.06.035_bib43","doi-asserted-by":"crossref","first-page":"W320-4","DOI":"10.1093\/nar\/gku316","article-title":"Deciphering key features in protein structures with the new ENDscript server","volume":"42","author":"Robert","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cell.2020.06.035_bib44","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","article-title":"Structural basis of receptor recognition by SARS-CoV-2","volume":"581","author":"Shang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cell.2020.06.035_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2381-y","article-title":"A human neutralizing antibody targets the receptor binding site of SARS-CoV-2","author":"Shi","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cell.2020.06.035_bib46","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s40266-018-0603-x","article-title":"Recombinant zoster vaccine (Shingrix\u00ae): A review in herpes zoster","volume":"35","author":"Syed","year":"2018","journal-title":"Drugs Aging"},{"key":"10.1016\/j.cell.2020.06.035_bib47","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.virol.2016.10.005","article-title":"A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection","volume":"499","author":"Tai","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.cell.2020.06.035_bib48","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1080\/21645515.2015.1021527","article-title":"Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus","volume":"11","author":"Tang","year":"2015","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.cell.2020.06.035_bib49","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/298347a0","article-title":"Synthesis and assembly of hepatitis B virus surface antigen particles in yeast","volume":"298","author":"Valenzuela","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.cell.2020.06.035_bib50","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1128\/jvi.64.3.1407-1409.1990","article-title":"Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization","volume":"64","author":"Vennema","year":"1990","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2020.06.035_bib51","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cell.2020.06.035_bib52","doi-asserted-by":"crossref","first-page":"e02015","DOI":"10.1128\/JVI.02015-19","article-title":"Molecular mechanism for antibody-dependent enhancement of coronavirus entry","volume":"94","author":"Wan","year":"2020","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2020.06.035_bib53","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/cr.2013.92","article-title":"Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4","volume":"23","author":"Wang","year":"2013","journal-title":"Cell Res."},{"key":"10.1016\/j.cell.2020.06.035_bib54","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bbrc.2014.07.090","article-title":"Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins","volume":"451","author":"Wang","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cell.2020.06.035_bib55","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.antiviral.2016.12.019","article-title":"Novel chimeric virus-like particles vaccine displaying MERS-CoV receptor-binding domain induce specific humoral and cellular immune response in mice","volume":"140","author":"Wang","year":"2017","journal-title":"Antiviral Res."},{"key":"10.1016\/j.cell.2020.06.035_bib56","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1016\/j.celrep.2019.08.052","article-title":"Structural definition of a neutralization-sensitive epitope on the MERS-CoV S1-NTD","volume":"28","author":"Wang","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.cell.2020.06.035_bib57","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0140-6736(20)30185-9","article-title":"A novel coronavirus outbreak of global health concern","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cell.2020.06.035_bib58","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3389\/fmicb.2020.00298","article-title":"Subunit vaccines against emerging pathogenic human coronaviruses","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.cell.2020.06.035_bib59","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","article-title":"Structural and functional basis of SARS-CoV-2 entry by using human ACE2","volume":"181","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cell.2020.06.035_bib60","doi-asserted-by":"crossref","first-page":"61","DOI":"10.46234\/ccdcw2020.023","article-title":"Description of the first strain of 2019-nCoV, C-Tan-nCoV Wuhan strain-National Pathogen Resource Center, China, 2020","volume":"2","author":"Wei","year":"2020","journal-title":"China CDC Weekly"},{"key":"10.1016\/j.cell.2020.06.035_bib61","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.cll.2009.07.007","article-title":"Recently discovered human coronaviruses","volume":"29","author":"Wevers","year":"2009","journal-title":"Clin. Lab. Med."},{"key":"10.1016\/j.cell.2020.06.035_bib62","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/pro.3330","article-title":"MolProbity: More and better reference data for improved all-atom structure validation","volume":"27","author":"Williams","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.cell.2020.06.035_bib63","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3390\/v11020174","article-title":"Global epidemiology of bat coronaviruses","volume":"11","author":"Wong","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.cell.2020.06.035_bib64","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1128\/JVI.01977-08","article-title":"Comparative analysis of complete genome sequences of three avian coronaviruses reveals a novel group 3c coronavirus","volume":"83","author":"Woo","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2020.06.035_bib65","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1126\/science.abc2241","article-title":"A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2","volume":"368","author":"Wu","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cell.2020.06.035_bib66","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bbrc.2004.07.084","article-title":"Oligomerization of the SARS-CoV S glycoprotein: dimerization of the N-terminus and trimerization of the ectodomain","volume":"322","author":"Xiao","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cell.2020.06.035_bib67","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cell.2020.06.035_bib68","doi-asserted-by":"crossref","first-page":"15092","DOI":"10.1038\/ncomms15092","article-title":"Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains","volume":"8","author":"Yuan","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2020.06.035_bib69","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.virusres.2014.11.013","article-title":"Receptor-binding domain-based subunit vaccines against MERS-CoV","volume":"202","author":"Zhang","year":"2015","journal-title":"Virus Res."},{"key":"10.1016\/j.cell.2020.06.035_bib70","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.celrep.2018.06.041","article-title":"Structural definition of a unique neutralization epitope on the receptor-binding domain of MERS-CoV spike glycoprotein","volume":"24","author":"Zhang","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.cell.2020.06.035_bib71","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1073\/pnas.1323279111","article-title":"Rapid generation of a mouse model for Middle East respiratory syndrome","volume":"111","author":"Zhao","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2020.06.035_bib72","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1038\/s41467-019-10897-4","article-title":"Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2020.06.035_bib73","doi-asserted-by":"crossref","first-page":"E60","DOI":"10.3390\/v11010060","article-title":"Advances in MERS-CoV vaccines and therapeutics based on the receptor-binding domain","volume":"11","author":"Zhou","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.cell.2020.06.035_bib74","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N.\u00a0Engl. J. Med."}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867420308126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867420308126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T11:44:55Z","timestamp":1758800695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867420308126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0092867420308126"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2020.06.035","relation":{},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2020.06.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}